🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Omar Nadeem Dana-Farber The study demonstrates that depth of response matters in high risk smoldering myeloma and builds on all the amazing work from prior studies of Len-dex in SMM. More to come to change the landscape of SMM #mmsm.

Omar Nadeem Dana-Farber The data also demonstrates that WGS can inform genomic changes in SMM beyond cytogenetics and that single cell sequencing shows immune cell function matters to predict risk and response to therapy #mmsm

Daratumumab paves the way for early intervention in HR-SMM Irene Ghobrial #mmsm nature.com/articles/s4157…

⌛️#ESHMM2025 THE DEADLINE TO SUBMIT IS TONIGHT AT 23:59 CET! Last chance: PROCEED NOW ➡ bit.ly/3THZibM 5th How to Diagnose & Treat MULTIPLE #MYELOMA 🗓️ April 3-5, 2025 in Vienna 🇦🇹 Chairs: Prof. Dr. Hermann Einsele, Maria Krauth, marivi mateos, Omar Nadeem #ESHCONFERENCES #MMsm

Efficacy results from the trial reveal that at a median follow-up of 50 months (range, 8-61) the primary end point of progression-free survival was not reached (NR; 95% CI, 57.7-NR). #mmsm | Omar Nadeem cancernetwork.com/view/response-…

Panelists discuss how emerging therapies like bispecific antibodies, CAR T cells, and novel drug combinations are reshaping treatment options for patients with relapsed/refractory multiple myeloma. #mmsm | Al Garfall Omar Nadeem Surbhi Sidana, MD cancernetwork.com/view/brief-ove…

CEPHEUS out! 👏 Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 et al. PFS ⬆️ ⬆️ with quad in ø ASCT #MMsm. Nice discussion of similarities (many) & differences (few) vs IMROZ. 📢 CD38-VRd now the norm for many: time to shift algorithms to quad-eligible vs not regardless of ASCT plans! nature.com/articles/s4159…

📣 CHECK OUT THE MAIN SCIENTIFIC TOPICS OF #ESHMM2025! Learn more and register here ➡ bit.ly/3THZibM 5th How to Diagnose & Treat MULTIPLE #MYELOMA 🗓️ Join us on April 3-5, 2025 in Vienna 🇦🇹 Chairs: Prof. Dr. Hermann Einsele, Maria Krauth, marivi mateos, Omar Nadeem #ESHCONFERENCES #MMsm

We are looking for a clinical investigator to join our growing team! Looking for candidates with particular interest in precursor myeloma Dana-Farber #mmsm

The #IBC2025 Workshop is officially here!✨ We're excited to hear the latest in CLL, lymphoma, CHIP, MGUS, and more! Stay tuned - we'll be sharing our expert interviews from this meeting in the coming days! 🎥 #MMsm #LeuSM #LymSM #MDSsm

Always a pleasure to be at #IBC2025 annual meeting focused on precursor hematologic malignancies!

Please join us for an exciting meeting to discuss the current updates in diagnosis and management of multiple myeloma #mmsm

Kicking off #ESHMM2025 filled with great talks and discussion about diagnosis and management of multiple myeloma #mmsm

#ESHMM2025 Thank You to everyone who joined us at the conference! Special thanks to Prof. Dr. Hermann Einsele Maria Krauth marivi mateos Omar Nadeem for an inspiring programme, to the faculty for sharing your insights & expertise & to all participants for your engagement. #ESHCONFERENCES

For those at #AACR25 come join our session of “Myeloma as a Model for Early Interception” covering topics of biology of precursor MM Gaddy Getz , screening for MGUS Sigurdur Kristinsson and role of early intervention co-chaired with Gaddy Getz #AACR2025 #mmsm

If you are attending the session on early myeloma intervention at #AACR25, check out this clinical and regulatory perspective by Irene Ghobrial coauthored by speaker Sigurdur Kristinsson, Cochair speaker Omar Nadeem: brnw.ch/21wSiHN AACR

Look forward to presenting at the dietary forum - testing diet with the rigor of drug at 5 pm today at #AACR25 AACR with Marcus Goncalves and Jennifer McQuade Come join us for this discussion! Memorial Sloan Kettering Cancer Center MSK Department of Medicine

Thanks VuMedi for featuring our Blood Advances piece around driving restrictions following CAR-T therapy in MM. Driving cars after CARs: an easy Twitter pun but a fundamentally important issue for pts. Data don't support 8-week driving restrictions! vumedi.com/video/driving-…

Looking forward to chairing our session on Monday at #ASCO2025 discussing all topics related to precursor hematologic malignancies with Dr Jennifer Woyach and Dr. Pinkal Desai #mmsm

Curious about the latest research in #myeloma treatment? Dr. Faith E Davies & Dr. Omar Nadeem break down key updates from #ASCO25 and #EHA2025 during our Patient Livestream on 7/9 at 3pm ET. RSVP here: ow.ly/2ALv50Wkrjo #mmsm